European Pharmaceutical Review
in 2 months
AAPS National Biotechnology Conference
11 May 2026 - 14 May 2026 - All Day Sheraton San Diego Resort 1380 Harbor Island Dr. San Diego
Awaiting Analysis
Your Intelligent Edge in Biopharma
KumbyAI is the AI-powered analyst that synthesizes news, identifies risks, and delivers actionable intelligence for quality and compliance professionals.
Latest Intelligence
A real-time look at the news KumbyAI is analyzing right now.
View
Fierce Biotech
less than a minute ago
Thermo Fisher unveils test to aid in dosing of antirejection drug
Thermo Fisher Scientific is launching a new test it says can help doctors avoid the “trial-and-error” approach typically used to dose patients with a common antirejection drug after organ transplant surgery.
Awaiting Analysis
Fierce Biotech
less than a minute ago
Behind Generate's 'feverish' race to raise $400M IPO while window remains open
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers.
Awaiting Analysis
Fierce Pharma
less than a minute ago
Partnering to Advance Drug Delivery Innovation
In this webinar, which is a rebroadcast from the 2025 PODD Conference, business development and technology assessment professionals actively involved in the scouting and evaluating of novel delivery technologies, discuss the constantly evolving topic of partnering.
Awaiting Analysis
Fierce Pharma
less than a minute ago
How Pharma is Expanding its Global Footprint to Advance Clinical Research
This webinar addresses how pharmaceutical organizations are expanding their clinical trial operations globally to support evolving portfolios and react to geopolitics.
Awaiting Analysis
Fierce Pharma
less than a minute ago
'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
As it ramps up its rollout of the first twice-yearly HIV pre-exposure prophylaxis medicine, Gilead Sciences is tapping into a beloved early-aughts track to familiarize consumers with Yeztugo.
Awaiting Analysis